White House Agrees to FDA’s Guidelines for Vetting Covid-19 Vaccines
The White House cast aside its objections and endorsed the U.S. Food and Drug Administration’s plans for assessing whether a Covid-19 vaccine should be given widely, making it likely that a shot won’t be cleared until after the election, people familiar with the matter said.
The FDA issued the guidelines soon afterward on Tuesday afternoon, saying it hopes the release “helps the public understand our science-based decision-making process that assures vaccine quality, safety and efficacy for any vaccine that is authorized or approved.”
The White House had been simply holding the guidelines for review and then approved them without changes, a senior administration official said.
A spokeswoman for the White House’s Office of Management and Budget said, “OMB officials…